Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer

Adam Shlien(Hospital for Sick Children), Peter J. Campbell(Wellcome Sanger Institute), Fabio Fuligni(Hospital for Sick Children), Sandrine Boyault(Université Claude Bernard Lyon 1), Keiran Raine(Wellcome Sanger Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Roland Arnold(Cancer Research UK), David Jones(European Bioinformatics Institute), Violetta Barbashina(Institute of Cancer Research), Lira Mamanova(Wellcome Sanger Institute), Manasa Ramakrishna(Wellcome Sanger Institute), Serge Dronov(Wellcome Sanger Institute), Åke Borg(Lund University), Anne Vincent‐Salomon(Université Paris Sciences et Lettres), Patrick Tarpey(Wellcome Sanger Institute), Torill Sauer(Oslo University Hospital), Young Seok Ju(Kim's Eye Hospital), Michael R. Stratton(Wellcome Sanger Institute), Odette Mariani(Institut Curie), Serena Nik‐Zainal(University of Cambridge), Samuel Aparício(BC Cancer Agency), Andrej Rosic(Hospital for Sick Children), Helen Davies(German Cancer Research Center), John Marshall(Wellcome Sanger Institute), Elli Papaemmanuil(Memorial Sloan Kettering Cancer Center), Peter Van Loo(Wellcome Sanger Institute), Sancha Martin(Wellcome Sanger Institute), Elizabeth Anderson(Wellcome Sanger Institute), Susanna L. Cooke(Wellcome Sanger Institute), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Anita Langerød(Oslo University Hospital), Øystein Garred(Oslo University Hospital), Aquila Fatima(Dana-Farber Cancer Institute), David C. Wedge(University of Manchester), Andrea L. Richardson(Brigham and Women's Hospital), Claire Hardy(Wellcome Sanger Institute)
Cell Reports
August 1, 2016
Cited by 45


Related Papers